Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity - Gutzmer, R; Koop, A; Meier, F (Eur J Cancer, 2017)
, et al; German Dermatooncology Group (DeCOG).